G Belcher

2.2k total citations
34 papers, 1.2k citations indexed

About

G Belcher is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, G Belcher has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Physiology. Recurrent topics in G Belcher's work include Pain Mechanisms and Treatments (8 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). G Belcher is often cited by papers focused on Pain Mechanisms and Treatments (8 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (5 papers). G Belcher collaborates with scholars based in United Kingdom, United States and Sweden. G Belcher's co-authors include R. W. Ryall, R. Schaffner, Howard L. Fields, H R Watson, Greg Zorman, John E. Adams, Guntram Schernthaner, M Hanefeld, Matthews Dr and Richard Urquhart and has published in prestigious journals such as Gastroenterology, The Journal of Physiology and Brain Research.

In The Last Decade

G Belcher

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Belcher United Kingdom 19 551 441 357 250 207 34 1.2k
David N. Herrmann United States 16 567 1.0× 414 0.9× 156 0.4× 137 0.5× 77 0.4× 33 1.5k
P. Milner United Kingdom 22 560 1.0× 690 1.6× 372 1.0× 263 1.1× 111 0.5× 42 1.5k
Gail J. Harty United States 19 723 1.3× 562 1.3× 450 1.3× 271 1.1× 97 0.5× 44 1.5k
Anna P. Malykhina United States 21 287 0.5× 204 0.5× 308 0.9× 132 0.5× 48 0.2× 70 1.4k
Ross King United Kingdom 3 300 0.5× 322 0.7× 198 0.6× 109 0.4× 54 0.3× 3 1.0k
M. J. Moss United States 16 413 0.7× 385 0.9× 194 0.5× 307 1.2× 106 0.5× 35 1.2k
A T Birmingham United Kingdom 17 251 0.5× 248 0.6× 462 1.3× 99 0.4× 75 0.4× 47 1.1k
Stella O. Page United States 14 222 0.4× 312 0.7× 542 1.5× 178 0.7× 272 1.3× 18 1.4k
Emiliano S. Higuera United States 7 993 1.8× 419 1.0× 544 1.5× 151 0.6× 21 0.1× 7 1.3k
Jianwei Jiang China 15 310 0.6× 157 0.4× 245 0.7× 77 0.3× 56 0.3× 39 1.0k

Countries citing papers authored by G Belcher

Since Specialization
Citations

This map shows the geographic impact of G Belcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Belcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Belcher more than expected).

Fields of papers citing papers by G Belcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Belcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Belcher. The network helps show where G Belcher may publish in the future.

Co-authorship network of co-authors of G Belcher

This figure shows the co-authorship network connecting the top 25 collaborators of G Belcher. A scholar is included among the top collaborators of G Belcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Belcher. G Belcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hyde, Robert, Carmen Bozic, G Belcher, et al.. (2009). FP33-WE-04 Utilization and safety of natalizumab in patients with relapsing multiple sclerosis in the post-marketing setting. Journal of the Neurological Sciences. 285. S110–S110. 2 indexed citations
2.
3.
Belcher, G, et al.. (2005). Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes. Diabetes Research and Clinical Practice. 70(1). 53–62. 71 indexed citations
4.
Belcher, G & Guntram Schernthaner. (2005). Changes in liver tests during 1‐year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide. Diabetic Medicine. 22(8). 973–979. 34 indexed citations
5.
Belcher, G, et al.. (2004). Cardiovascular effects of treatment of type 2 diabetes with pioglitazone, metformin and gliclazide. International Journal of Clinical Practice. 58(9). 833–837. 35 indexed citations
6.
Hanefeld, M & G Belcher. (2001). Safety profile of pioglitazone.. PubMed. 27–31. 31 indexed citations
7.
Skene, Allan M., et al.. (2000). Graft material and results of platelet inhibitor trials in peripheral arterial reconstructions: reappraisal of results from a meta‐analysis. British Journal of Clinical Pharmacology. 49(5). 479–483. 5 indexed citations
8.
Belcher, G & Matthews Dr. (2000). Safety and tolerability of pioglitazone. Experimental and Clinical Endocrinology & Diabetes. 108(Sup. 2). 267–273. 30 indexed citations
9.
Watson, H R, Richard M. Robb, G Belcher, & J. J. F. Belch. (1999). Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.. PubMed. 26(8). 1734–7. 27 indexed citations
10.
Dormandy, John, G Belcher, Paul Broos, et al.. (1994). Prospective study of 713 below–knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. British journal of surgery. 81(1). 33–37. 65 indexed citations
11.
Watson, H R, et al.. (1992). Iloprost in Cardiopulmonary Bypass Procedures. Birkhäuser Basel eBooks. 346–353. 1 indexed citations
12.
Belcher, G, et al.. (1992). Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon.. PubMed. 19(9). 1403–6. 38 indexed citations
13.
Isenberg, David, M.H.A. RUSTIN, G Belcher, et al.. (1988). SUCCESSFUL TREATMENT OF RAYNAUD'S SYNDROME WITH ILOPROST, A CHEMICALLY STABLE PROSTACYCLIN ANALOGUE. Lara D. Veeken. 27(3). 220–226. 48 indexed citations
14.
Zorman, Greg, G Belcher, John E. Adams, & Howard L. Fields. (1982). Lumbar intrathecal naloxone blocks analgesia produced by microstimulation of the ventromedial medulla in the rat. Brain Research. 236(1). 77–84. 106 indexed citations
15.
Belcher, G, T. Smock, & Howard L. Fields. (1982). Effects of intrathecal ACTH on opiate A algesia in the rat. Brain Research. 247(2). 373–377. 19 indexed citations
16.
Belcher, G & R. W. Ryall. (1978). Differential excitatory and inhibitory effects of opiates on non-nociceptive and nociceptive neurones in the spinal cord of the cat. Brain Research. 145(2). 303–314. 75 indexed citations
17.
Belcher, G, R. W. Ryall, & R. Schaffner. (1978). The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurones in the cat. Brain Research. 151(2). 307–321. 294 indexed citations
18.
Belcher, G. (1977). Correlation between effects of brain-stem stimulation and effects of 5-hydroxytryptamine and noradrenaline on non-nociceptive and nociceptive spinal interneurones [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(1). 149P–150P. 3 indexed citations
19.
Belcher, G & R. W. Ryall. (1977). Substance P and Renshaw cells: a new concept of inhibitory synaptic interactions.. The Journal of Physiology. 272(1). 105–119. 104 indexed citations
20.
Ryall, R. W. & G Belcher. (1977). Substance P selectively blocks nicotinic receptors on Renshaw cells: a possible synaptic inhibitory mechanism. Brain Research. 137(2). 376–380. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David N. Herrmann Breakdown of academic impact, for papers by P. Milner Breakdown of academic impact, for papers by Gail J. Harty Breakdown of academic impact, for papers by Anna P. Malykhina Breakdown of academic impact, for papers by Ross King Breakdown of academic impact, for papers by M. J. Moss Breakdown of academic impact, for papers by A T Birmingham Breakdown of academic impact, for papers by Stella O. Page Breakdown of academic impact, for papers by Emiliano S. Higuera Breakdown of academic impact, for papers by Jianwei Jiang
Rankless by CCL
2026